持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/08/21 | 日証協 | 127,161株 | -0.25% | 11,880株 | +39.42% | 157,791株 | -2.71% | 21,700株 | +10.25% |
2020/08/14 | 日証協 | 127,481株 | +1.11% | 8,521株 | -26.14% | 162,191株 | +1.22% | 19,683株 | -37.03% |
2020/08/07 | 日証協 | 126,081株 | -1.36% | 11,537株 | -47.59% | 160,229株 | 0% | 31,258株 | -10.12% |
2020/07/22 | 日証協 | 118,963株 | -7.4% | 7,535株 | -65.21% | 154,515株 | -3.68% | 20,879株 | -41.84% |
2020/07/17 | 日証協 | 128,463株 | -1.66% | 21,660株 | +114.9% | 160,415株 | -9.1% | 35,900株 | -22.63% |
2020/07/10 | 日証協 | 130,628株 | +0.23% | 10,079株 | -7.68% | 176,480株 | +12.21% | 46,398株 | -20.21% |
2020/07/03 | 日証協 | 130,328株 | +0.11% | 10,918株 | -53.87% | 157,280株 | -0.39% | 58,151株 | +33.07% |
2020/06/26 | 日証協 | 130,181株 | +6.99% | 23,667株 | +739.85% | 157,901株 | +7.97% | 43,700株 | +71.51% |
2020/06/12 | 日証協 | 124,881株 | +2.21% | 12,188株 | -29.66% | 157,650株 | -0.37% | 47,700株 | +0.4% |
2020/06/05 | 日証協 | 122,181株 | -8.82% | 17,328株 | +229.43% | 158,241株 | -10.07% | 47,509株 | -6.54% |
2020/05/29 | 日証協 | 133,995株 | -7.85% | 5,260株 | -63.74% | 175,955株 | -7.62% | 50,833株 | +52.19% |
2020/05/22 | 日証協 | 145,408株 | -1.97% | 14,506株 | -57.88% | 190,475株 | -1.45% | 33,400株 | +154.69% |
2020/05/15 | 日証協 | 148,329株 | +10.69% | 34,442株 | +43.42% | 193,275株 | -0.88% | 13,114株 | -40.39% |
2020/05/08 | 日証協 | 134,000株 | +13.75% | 24,014株 | -5.46% | 194,989株 | +11.3% | 22,000株 | -16.67% |
2020/05/01 | 日証協 | 117,800株 | -1.01% | 25,400株 | -33.85% | 175,189株 | -10.02% | 26,400株 | -22.8% |
2020/04/24 | 日証協 | 119,000株 | +19.62% | 38,396株 | +90.1% | 194,689株 | +3.41% | 34,196株 | +27.37% |
2020/04/17 | 日証協 | 99,479株 | -10.18% | 20,198株 | -71.16% | 188,268株 | -2.16% | 26,847株 | -60.96% |
2020/04/10 | 日証協 | 110,752株 | +28.83% | 70,031株 | +144.19% | 192,420株 | +5.19% | 68,761株 | -12.1% |
2020/04/03 | 日証協 | 85,967株 | -29.92% | 28,679株 | -52.75% | 182,929株 | -19.58% | 78,227株 | +12.57% |
※株式分割は考慮していませんのでご注意ください。
Page Top